Charles River Laboratories stock pre-market as Cooke & Bieler cites demand stabilization
Published on 09/30/2026 at 08:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Charles River Laboratories stock is in focus pre-market after Cooke & Bieler highlighted the company in its second-quarter 2026 investor letter. Charles River Laboratories International, Inc. trades under the ticker CRL on the New York Stock Exchange, according to Yahoo Finance.
Investor letter highlights demand
Cooke & Bieler’s second-quarter 2026 investor letter identified Charles River Laboratories as the second-largest contributor to the Mid Cap Value Equity Strategy. The letter said the company reported better-than-expected first-quarter earnings and described the results as support for its view that demand was stabilizing after a period of cyclical contraction. Those comments were attributed to the investment manager by Yahoo Finance.
Disclaimer...
en | boerse | 70201874 |
